Daiwa Sb Investments Ltd. buys $10,168,070 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Daiwa Sb Investments Ltd. scooped up 15,280 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 8, 2016. The investment management firm now holds a total of 126,500 shares of Cardinal Health Inc which is valued at $10,168,070.Cardinal Health Inc makes up approximately 2.91% of Daiwa Sb Investments Ltd.’s portfolio.

Other Hedge Funds, Including , Bnp Paribas Arbitrage Sa reduced its stake in CAH by selling 46,299 shares or 28.04% in the most recent quarter. The Hedge Fund company now holds 118,847 shares of CAH which is valued at $9,552,922. Cardinal Health Inc makes up approx 0.04% of Bnp Paribas Arbitrage Sa’s portfolio.First Financial Bank N.a. – Trust Division boosted its stake in CAH in the latest quarter, The investment management firm added 25 additional shares and now holds a total of 4,124 shares of Cardinal Health Inc which is valued at $322,621. Cardinal Health Inc makes up approx 0.06% of First Financial Bank N.a. – Trust Division’s portfolio.Integrated Investment Consultants boosted its stake in CAH in the latest quarter, The investment management firm added 195 additional shares and now holds a total of 1,459 shares of Cardinal Health Inc which is valued at $114,138. Cardinal Health Inc makes up approx 0.06% of Integrated Investment Consultants’s portfolio.

Cardinal Health Inc opened for trading at $82.14 and hit $82.87 on the upside on Wednesday, eventually ending the session at $82.28, with a gain of 0.62% or 0.51 points. The heightened volatility saw the trading volume jump to 19,42,567 shares. Company has a market cap of $26,808 M.

On the company’s financial health, Cardinal Health Inc reported $1.43 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.33. The company had revenue of $30662.00 million for the quarter, compared to analysts expectations of $30439.59 million. The company’s revenue was up 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016. Avondale Initiated Cardinal Health Inc on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.